Today: 9 June 2026
Ashtead share price slips after buyback update as NYSE switch nears
2 February 2026
2 mins read

Ashtead share price slips after buyback update as NYSE switch nears

London, Feb 2, 2026, 09:24 GMT — Regular session

  • Shares of Ashtead slipped 0.45% in early London dealings, trading close to 4,666 pence.
  • The company revealed an additional tranche of share repurchases as part of its $1.5 billion buyback programme.
  • Investors are eyeing a Feb. 6 dividend along with moves set for late February linked to the planned U.S. primary listing.

Ashtead Group plc (AHT.L) shares slid 0.45% to 4,666 pence by 0924 GMT, hitting a session low of 4,650 pence earlier.

The move keeps focus on Ashtead’s cash-return programme as the stock seeks to find its footing after a tough week. Buybacks, which involve a company buying back its own shares, can boost earnings per share by lowering the share count — but on their own, they seldom shift sentiment.

Ashtead has turned into a timing play. With a U.S. primary listing set just weeks ahead, index trackers are gearing up for the ripple effects.

On Monday, Ashtead revealed it acquired 79,000 ordinary shares for its treasury on Jan. 30, paying an average of 4,743.6024 pence each. J.P. Morgan Securities plc handled the brokerage. Following the transaction, Ashtead had 415,427,846 shares outstanding, excluding those held in treasury, which stood at 35,926,987 shares.

Since late January, the shares have taken a sharp tumble. Ashtead ended Friday at 4,687 pence, roughly 9% off its January 28 close of 5,112 pence. That puts it about 17% below its 52-week peak, based on price data.

Risk appetite took a hit as global shares dropped, following a sharp selloff in precious metals that triggered broad position cuts. One strategist called it a sudden flip in markets, fueled by a rush to unwind crowded trades.

Ashtead has pegged its next key income figure to the interim dividend, set at 37.5 U.S. cents per share. That translates to 27.60 pence, based on an exchange rate of 1.3586 GBP/USD. The dividend payment is scheduled for Feb. 6, with the register cut-off on Jan. 9.

Late February marks key steps in the U.S. listing process. Ashtead announced that Sunbelt Rentals Holdings filed a Form 10 registration statement with the SEC on Jan. 27. This filing is set to become effective on Feb. 26. Following that, the UK court scheme of arrangement is expected to clear on Feb. 27, making Sunbelt the holding company. The company also indicated that trading admission in New York and a secondary London listing under the “SUNB” ticker should start on March 2, subject to usual conditions. Investegate

FTSE Russell warned of index changes following the move. Ashtead shares will be swapped one-for-one for Sunbelt shares, it said. Ashtead is set to drop out of the FTSE UK Index Series at the open on March 2, with February 27 marked as the scheme’s effective date and the final day to trade Ashtead stock.

Ashtead, widely recognized for its Sunbelt Rentals brand in North America, operates in a cyclical segment tied closely to construction and industrial demand. Investors often compare it to U.S.-listed peer United Rentals when speculating on the stock’s trajectory following the listing switch.

Still, the operating performance remains the key focus, not just the financial mechanics. Ashtead’s half-year adjusted pretax profit came up short in December, dragged down by rising internal repair expenses and a dip in hurricane-related demand during Q2. This showed how margins can slip even if revenue stays steady.

Traders will next focus on the Feb. 6 dividend payout, the anticipated Feb. 26 effectiveness date for the Form 10, and if the Feb. 27 scheme timetable holds firm before the March 2 admission window.

Stock Market Today

  • Alibaba Stock Falls 18% Amid Heavy AI Investment
    June 9, 2026, 10:38 AM EDT. Alibaba shares have dropped 18% year-to-date, weighed down by the company's aggressive spending on artificial intelligence (AI) initiatives. This investment strategy has raised concerns among investors about its impact on short-term profitability. The stock's decline outpaces broader market trends and highlights the risks tech giants face when prioritizing long-term innovation over immediate earnings. Analysts note the move reflects Alibaba's commitment to staying competitive in the evolving technology landscape despite near-term challenges.

Latest articles

Autozi Shares Jump 400%, Filing Flags Risks for AZI

Autozi Shares Jump 400%, Filing Flags Risks for AZI

9 June 2026
Autozi Internet Technology shares soared over 400% to $5.69 in early Nasdaq trading after a 10-for-1 share consolidation slashed its share count to about 4.49 million, but the surge contrasts with a 63.1% revenue drop, 82.5% plunge in gross profit, and widened net loss, with the company warning of “substantial doubt” about its ability to continue as a going concern.
Redwire Shares Slip After $500 Million Stock Offering Filed

Redwire Shares Slip After $500 Million Stock Offering Filed

9 June 2026
Redwire Corp shares plunged 6.5% to $17.37 after launching a $500 million at-the-market stock program, raising dilution risks for investors as the company seeks flexible funding despite recent record backlog and strong revenue growth; the drop contrasted with gains at other space stocks, highlighting investor concern over potential share issuance.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
ST Engineering share price slips after NeuSAR-2 satellite plan and Singapore’s new space agency
Previous Story

ST Engineering share price slips after NeuSAR-2 satellite plan and Singapore’s new space agency

Samsung Electronics stock price dives 6% in Seoul selloff — what to watch before Tuesday’s open
Next Story

Samsung Electronics stock price dives 6% in Seoul selloff — what to watch before Tuesday’s open

Go toTop